Cargando…

Improving diagnosis of mitochondrial fatty-acid oxidation disorders

Detalles Bibliográficos
Autores principales:	Vianey-Saban, Christine, Fouilhoux, Alain, Vockley, Jerry, Acquaviva-Bourdain, Cécile, Guffon, Nathalie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Viewpoint
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995306/ https://www.ncbi.nlm.nih.gov/pubmed/36599942 http://dx.doi.org/10.1038/s41431-022-01260-1

Ejemplares similares

Carglumic acid: an additional therapy in the treatment of organic acidurias with hyperammonemia?
por: Levrat, Virginie, et al.
Publicado: (2008)

LC-MS/MS multiplex analysis of lysosphingolipids in plasma and amniotic fluid: A novel tool for the screening of sphingolipidoses and Niemann-Pick type C disease
por: Pettazzoni, Magali, et al.
Publicado: (2017)

A rare late progression form of Sly syndrome mucopolysaccharidosis
por: Guffon, Nathalie, et al.
Publicado: (2019)

Mitochondrial morphology, bioenergetics and proteomic responses in fatty acid oxidation disorders
por: Raimo, Serena, et al.
Publicado: (2021)

Very long‐term outcomes in 23 patients with cblA type methylmalonic acidemia
por: Marelli, Cecilia, et al.
Publicado: (2022)

Impact of newborn screening on the reported incidence and clinical outcomes associated with medium- and long-chain fatty acid oxidation disorders
por: Marsden, Deborah, et al.
Publicado: (2021)

Monitoring of asparagine depletion and anti-l-asparaginase antibodies in adult acute lymphoblastic leukemia treated in the pediatric-inspired GRAALL-2005 trial
por: Paillassa, Jérôme, et al.
Publicado: (2018)

Primary hyperoxaluria type 1: pathophysiology and genetics
por: Fargue, Sonia, et al.
Publicado: (2022)

Physiological Perspectives on the Use of Triheptanoin as Anaplerotic Therapy for Long Chain Fatty Acid Oxidation Disorders
por: Sklirou, Evgenia, et al.
Publicado: (2021)

n-3 fatty acids, γ-linolenic acid, and antioxidants in sepsis
por: Das, Undurti N
Publicado: (2013)

Different Lipid Signature in Fibroblasts of Long-Chain Fatty Acid Oxidation Disorders
por: Alatibi, Khaled I., et al.
Publicado: (2021)

Lipidomic and Proteomic Alterations Induced by Even and Odd Medium-Chain Fatty Acids on Fibroblasts of Long-Chain Fatty Acid Oxidation Disorders
por: Alatibi, Khaled I., et al.
Publicado: (2021)

Metabolomic Profiling of Fatty Acid and Amino Acid Metabolism in Youth With Obesity and Type 2 Diabetes: Evidence for enhanced mitochondrial oxidation
por: Mihalik, Stephanie J., et al.
Publicado: (2012)

Dietary management and major clinical events in patients with longchain fatty acid oxidation disorders enrolled in a phase 2 triheptanoin study
por: Vockley, Jerry, et al.
Publicado: (2020)

Mitochondrial Fatty Acid Oxidation Disorders: Laboratory Diagnosis, Pathogenesis, and the Complicated Route to Treatment
por: Wanders, Ronald J.A., et al.
Publicado: (2020)

Ethical Implications of the Use of Language Analysis Technologies for the Diagnosis and Prediction of Psychiatric Disorders
por: Loch, Alexandre Andrade, et al.
Publicado: (2022)

Biochemical Markers for the Diagnosis of Mitochondrial Fatty Acid Oxidation Diseases
por: Ruiz-Sala, Pedro, et al.
Publicado: (2021)

The Challenges of Mitochondrial Replacement
por: Chinnery, Patrick F., et al.
Publicado: (2014)

Blood cytokine patterns suggest a modest inflammation phenotype in subjects with long‐chain fatty acid oxidation disorders
por: McCoin, Colin S., et al.
Publicado: (2019)

Access to prompt diagnosis: The missing link in preventing mental health disorders associated with neglected tropical diseases
por: Picado, Albert, et al.
Publicado: (2019)

Omega-6 vegetable oils as a driver of coronary heart disease: the oxidized linoleic acid hypothesis
por: DiNicolantonio, James J, et al.
Publicado: (2018)

Efficacy and safety of i.v. sodium benzoate in urea cycle disorders: a multicentre retrospective study
por: Husson, Marie-Caroline, et al.
Publicado: (2016)

An eHealth Framework for Managing Pediatric Growth Disorders and Growth Hormone Therapy
por: Dimitri, Paul, et al.
Publicado: (2021)

Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle
por: Knottnerus, Suzan J. G., et al.
Publicado: (2018)

Regulation of the mitochondrial permeability transition pore and its effects on aging
por: Pellegrino-Coppola, Damiano
Publicado: (2020)

Inhibition of adaptive therapy tolerance in cancer: is triplet mitochondrial targeting the key?
por: Westermarck, Jukka
Publicado: (2023)

Effects of triheptanoin (UX007) in patients with long‐chain fatty acid oxidation disorders: Results from an open‐label, long‐term extension study
por: Vockley, Jerry, et al.
Publicado: (2020)

Limitations in the Diagnosis of Noncompaction Cardiomyopathy by Echocardiography
por: Hotta, Viviane Tiemi, et al.
Publicado: (2017)

Is it Time to Retire the Diagnosis “Hypertensive Emergency”?
por: Fuchs, Flávio Danni, et al.
Publicado: (2023)

Indication or diagnosis should be required on prescriptions
por: Rupp, Michael T, et al.
Publicado: (2021)

Nursing Homes, the Pandemic, and Caring Enough
por: Gurwitz, Jerry H., et al.
Publicado: (2020)

DORA Declaration: Delayed Diagnosis of Debilitating Dilemma
por: Meo, Sultan Ayoub
Publicado: (2013)

Decades After Diagnosis: The Unrecognized Trauma of Surviving
por: Strong, Susan R.
Publicado: (2020)

Abdominal Fat Biopsy for the Diagnosis of Cardiac Amyloidosis
por: Aimo, Alberto, et al.
Publicado: (2020)

Telemedicine for Hyperkinetic Movement Disorders
por: Srinivasan, Ragini, et al.
Publicado: (2020)

Pro: Can neuropathology really confirm the exact diagnosis?
por: Esiri, Margaret M
Publicado: (2010)

Con: Can neuropathology really confirm the exact diagnosis?
por: Jellinger, Kurt A
Publicado: (2010)

The Problem of Questionable Dystonia in the Diagnosis of ‘Essential Tremor-Plus’
por: Pandey, Sanjay, et al.
Publicado: (2020)

Neuroangiostrongyliasis: Updated Provisional Guidelines for Diagnosis and Case Definitions
por: Graeff-Teixeira, Carlos, et al.
Publicado: (2023)

Regulation of cancer stem cells by p53
por: Jerry, D Joseph, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_n1ipc4pdsemfl8n24mjuc6domg